SNTI Senti Biosciences Holdings, Inc.

BEARISH Impact: 7/10 8-K
Horizon weeks Filed May 26, 2026 Processed 17d 20h ago SEC 0001628280-26-038058
8-K material event: Items 1.01
Latest settled — T+5d
SNTI ▼ -3.47% at T+5d
SHORT call ✓ call won +3.47% · α vs SPY +3.93% · entry $1.01 → $0.9750
Next anchor: T+20d in 11d
Currently $0.9600 · +4.95% from $1.01 entry (call sign-flipped)
Entry anchored
May 26, 2026
via day open
T+1d
-0.99%
call +0.99% · α +1.54%
$1.00
settled 17d ago
T+5d
-3.47%
call +3.47% · α +3.93%
$0.9750
settled 11d ago
T+20d
call — · α —
in 11d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Senti Biosciences issued $10.0M in aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24, creating a new secured debt obligation. The notes carry onerous terms including a 200% redemption premium upon default or change of control, a fixed exchange/conversion price of $0.6261 per share, and extensive negative covenants restricting the company's operations. The filing also discloses a potential transaction involving a contingent value right (CVR) of up to $60.0M tied to SENTI-202 milestones.

Key Financial Metrics

Deal Value
$10.0M

Actionable Insight

The $10M convertible note is highly dilutive at a fixed conversion price of $0.6261, representing significant potential dilution relative to the $31M market cap. The onerous terms (200% redemption premium, 12% default interest, extensive negative covenants) signal distressed financing. Monitor for stockholder approval requests and the CVR transaction proxy statement. The notes' senior secured status and redemption provisions create substantial downside risk for common equity holders.

Key Facts

  • $10.0M in aggregate principal amount of Senior Secured Convertible Notes issued to Celadon Partners SPV 24
  • Notes have a fixed exchange/conversion price of $0.6261 per share
  • Maturity date is 6 months from initial closing, extendable by holder upon default or change of control
  • 200% redemption premium on outstanding principal upon default, bankruptcy, or change of control
  • Interest accrues at 12% per annum only after an Event of Default
  • Notes are senior secured, ranking senior to all other indebtedness
  • Extensive negative covenants restrict incurring debt, liens, dividends, share repurchases, and affiliate transactions
  • Potential CVR transaction of up to $60.0M tied to SENTI-202 regulatory and sales milestones
  • Company intends to file proxy statement for stockholder approval of additional note issuances beyond Exchange Cap
  • Market cap is ~$31M; the $10M note represents ~32% of market cap

Financial Impact

$10.0M new secured debt, representing ~32% of $31M market cap; potential dilution from conversion at $0.6261/share; up to $60.0M CVR potential

debtdilutionleverage

Risk Factors

  • Massive potential dilution from note conversion at $0.6261/share relative to current market price
  • 200% redemption premium upon default or change of control creates severe cash liability
  • Extensive negative covenants severely restrict operational and financial flexibility
  • Potential CVR transaction could further complicate capital structure
  • Stockholder approval needed for additional note issuances beyond Exchange Cap

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-038058
Document: snti-20260520.htm0001628280-26-038058
Document: 0001628280-26-038058-index-headers.html0001628280-26-038058
Document: 0001628280-26-038058-index.html0001628280-26-038058
Document: 0001628280-26-038058.txt0001628280-26-038058
7 reports for SNTI
Performance horizon
0% Hit rate 0 of 4 directional calls best @ T+1· 0.00%May 1, 2026
Filters
Rows
Reports for SNTI — sortable, filterable
Type Now
May 26, 2026
17d ago
8-K
BEARISH ★ 7/10
$1.01 $0.9750▲ +3.47%▲ +3.93%$0.9600 (+4.95%)
May 14, 2026
4w ago
8-K
BULLISH ★ 7/10
$1.04 $0.9840▼ −5.38%▼ −4.67%$0.9600 (−7.69%)
May 14, 2026
4w ago
Press Release
BULLISH ★ 7/10
$1.04 $0.9840▼ −5.38%▼ −4.67%$0.9600 (−7.69%)
May 14, 2026
4w ago
Press Release
BULLISH ★ 8/10
$1.04 $0.9840▼ −5.38%▼ −4.67%$0.9600 (−7.69%)
May 8, 2026
5w ago
15-12G
NEUTRAL ★ 2/10
$1.02 $0.9400▼ −7.84%▼ −7.76%$0.9600 (−5.88%)
May 1, 2026
6w ago
424B5
BEARISH ★ 6/10
$0.9430 $1.02▼ −8.17%▼ −5.23%$0.9600 (−1.80%)
Mar 27, 2026
11w ago
Press Release
MIXED ★ 6/10
$0.7900 $0.9120▲ +15.44%▲ +11.58%$0.9600 (+21.52%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (45h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access